Navigation Links
Estonian Cancer Patients Have Access to More Conformal Radiotherapy Treatments for First Time with Unveiling of Advanced Varian Treatment Machine
Date:1/15/2009

TALLINN, Estonia, Jan. 15 /PRNewswire-FirstCall/ -- Cancer patients in Estonia now have access to advanced radiotherapy techniques, such as intensity modulated radiotherapy (IMRT), for the first time with the official unveiling shortly before Christmas of an advanced Varian Medical Systems treatment machine at the North Estonia Regional Hospital in the country's capital, Tallinn. The opening ceremony attracted publicity on Estonian national TV and in national newspapers.

North Estonia Regional Hospital, which serves two-thirds of Estonia's 1.4 million population, has doubled its linear accelerator capacity with the acquisition of a Varian Clinac(R) DHX equipped with a Millennium(TM) 120-leaf collimator, enabling more conformal radiotherapy treatment. "We have moved from conventional radiotherapy to conformal radiotherapy for the first time," says senior physicist Eduard Gerskevitch. "The collimator's finer leaves allow clinicians to conform the treatment beam tighter to the tumor and limit irradiation of normal healthy tissue.

"This new equipment has enabled us to improve the quality of our treatments while reducing waiting lists. Our waiting times have reduced from five weeks to three weeks, although we've achieved this with a heavy workload on our machines."

This workload increased shortly after the new machine arrived, when an older device at the only other Estonian radiotherapy hospital broke down and all that hospital's patients were transferred to the North Estonian Regional Hospital. "At present we are the only hospital in the country treating patients with a linear accelerator and we are extremely busy," said Maire Kuddu, chief radiation oncologist. Staff at the hospital are working double-shift on both machines as they attempt to cope with more than 130 patients a day.

Despite this heavy workload, the team has been able to introduce advanced IMRT for head and neck cancer patients. Intensity modulated radiotherapy enables clinicians to 'sculpt' the dose to the shape of the tumor and avoid more surrounding healthy tissue. For head and neck patients, it means more precise treatments and less potential harm to nearby salivary and parotid glands.

The new device was funded by the hospital with support from the International Atomic Energy Agency, which provided additional financing and helped to train staff in the use of the equipment, and the Environmental Investment Centre, which helped to decommission an older Cobalt-based treatment unit and refurbish the bunker for the new accelerator.

"We are delighted to be able to double both our own and the country's linear accelerator treatment capacity and introduce advanced radiotherapy techniques at the same time," adds Maire Kuddu. She said the hospital's future plans include equipping the new machine with an On-Board Imager(R) and introducing Varian's RapidArc(TM) capability for fast and precise image-guided IMRT.

"It is recognised that this is a major improvement in the country's cancer treatment capabilities but this is just a start," added Eduard Gerskevitch. "The number of treatment units is still very low compared with our needs and we will need to see further investment in radiotherapy in the future."

Editorial contact: Neil Madle, Varian Medical Systems, +44 7786 526068

About Varian Medical Systems

Varian Medical Systems, Inc. (NYSE: VAR), of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 4,800 people who are located at manufacturing sites in North America and Europe and in its 60 sales and support offices around the world. For more information, visit http://www.varian.com/.


'/>"/>
SOURCE Varian Medical Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Researchers Zero In on GI Cancers
2. Medical Experts Call for Obama Administration, Congress to Boost Funding for Prostate Cancer Imaging Research
3. Study shows surgery provides good long-term outcomes for patients with gastrointestinal cancers
4. NCC and Wyeth Donation to Assist Cancer Patients in Latin America
5. Researchers identify new protein that triggers breast cancer
6. U.S. and European Advocacy Groups Launch United, Global Campaign to Prevent Cervical Cancer
7. NCCN and SEHA Collaborate to Improve Cancer Care
8. Multiple Screening Strategy Boosts Cervical Cancer Detection
9. Ovary Removal Lowers Odds of Cancer in High-Risk Women
10. Colonoscopy Quality Critical Factor to Thorough Exam and Best Colon Cancer Detection
11. The PA Breast Cancer Coalition Urges You to Donate Your State Income Tax Refund to Breast and Cervical Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... The TouchPoint Solution, home of Buzzies ... stress and anxiety. , “Buzzies change the way we interact with stress and ... , Since its launch date in December 2016, The TouchPoint Solution has sold more ...
(Date:3/23/2017)... ... , ... ?This conference will prominently feature 150+ Hospital and Health System Executive Speakers including: , ... , 43rd President of the United States of America: George W. Bush , ... Out of the Ring: Sugar Ray Leonard , JD, Chairperson, McGuireWoods LLP: Amber ...
(Date:3/23/2017)... ... 23, 2017 , ... It’s that time of year again! Time to think ... summer internships , which can be frustrating when they don’t even know how to ... a boutique public relations firm outside of Philadelphia, have offered these three tips to ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... skincare products, was awarded as winners of American Dreams & Good Housekeeping Seal ... hosted jointly by HSN and Good Housekeeping. , Steven Wang, MD ., ...
(Date:3/23/2017)... , ... March 23, 2017 , ... News Advisory/Interview Opportunity ... has helped score a major victory in Europe for public health and the environment ... , Based on rigorous scientific research and the overwhelming support of European citizens, the ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... , March 23, 2017 Merrimack Pharmaceuticals, Inc. (NASDAQ: ... its first patient in a Phase 1 study of ... (ADN) that encapsulates a novel taxane and targets the ... in 50-100% of many major tumor types, including prostate, ... "The initiation of this study is an important step ...
(Date:3/23/2017)... WINNIPEG , March 23, 2017 /PRNewswire/ - ... a leading Canadian specialty pharmaceutical company, is pleased ... has received final approval from the U.S. Food ... new drug application ("ANDA") for tetrabenazine tablets in ... newly approved product is a generic equivalent of ...
(Date:3/23/2017)... SANTA MONICA, Calif. , March 23, 2017 /PRNewswire/ ... the launch of a native mobile app for the ... the standard for surgery coordination and communication for physician ... of a native mobile app offers iPhone users even ... "Casetabs is making it even easier to connect ...
Breaking Medicine Technology: